MDCT Evaluation of Ureteral Tumors: Advantages of 3D Reconstruction and Volume Visualization: Self-Assessment Module is organized by American Roentgen Ray Society (ARRS).
Date of issuance: November 22, 2013
Date of expiration: November 21, 2019
Estimated time to complete the activity: 1 hour(s)
The target audience for this activity is readers of the AJR, radiologists, radiologists-in-training, and other health professionals with an interest in the diagnosis and management of ureteral tumors.
The ARRS designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.
This activity meets the ABR's criteria for a self-assessment activity in the ABR Maintenance of Certification program. The ARRS has been granted SAM Deemed Status by the American Board of Radiology (ABR). This allows the ARRS to develop and implement, without prior ABR review, enduring SAMs that satisfy ABR Part II MOC requirements. The modules designated as SAMs qualify as self-assessment modules and meet the ABR SAM requirements. 1.00 SAM credit will be given in the ABR category C04 Genitourinary for completion of this activity.
Goals and Objectives:
After completing the material in this article, the learner should be able to:
• Discuss the practical applications of different CT urography protocols and 3D reconstructions in evaluating patients with suspected ureteral disease; and
• Describe and recognize CT findings suggestive of ureteral malignancy.